Improved medication use in long-term care: Building on the consultant pharmacist's drug regimen review

American Journal of Managed Care

Volumn 8, Issue 4, 2002, Pages 318-326

  Harjivan, Chandresh ^a   Lyles, Alan ^a  

^a UNIVERSITY OF BALTIMORE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; NEUROLEPTIC AGENT;

DRUG SURVEILLANCE PROGRAM; DRUG USE; ELDERLY CARE; EVIDENCE BASED MEDICINE; FEASIBILITY STUDY; GERIATRIC CARE; GERIATRIC DISORDER; HEALTH CARE UTILIZATION; HUMAN; LONG TERM CARE; MANAGED CARE; MEDICAID; MEDICAL AUDIT; MEDICARE; MENTAL DISEASE; OUTCOMES RESEARCH; PHARMACIST; PRIORITY JOURNAL; REVIEW;

AGED; ARTHRITIS, RHEUMATOID; CERTIFICATION; CONSULTANTS; DRUG UTILIZATION REVIEW; FEASIBILITY STUDIES; FEMALE; HUMANS; LONG-TERM CARE; MALE; MODELS, ORGANIZATIONAL; OUTCOME ASSESSMENT (HEALTH CARE); PHARMACISTS; UNITED STATES; UNITED STATES CENTERS FOR MEDICARE AND MEDICAID SERVICES;

EID: 0036110779     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Drug therapy
2. Drug-related morbidity and mortality. A cost-of-illness model
3. Medication use and the elderly: Current status and opportunities
4. General and psychotherapeutic medication use in 878 nursing facilities: A 1997 national survey
5. Suboptimal medication use in the elderly. The tip of the iceberg
6. Pharmacotherapy problems in the elderly
7. Recent trends and controversies in industry sponsored clinical trials
8. Adverse drug reaction-related hospitalizations of nursing facility patients: A 4-year study
9. National Center for Health Statistics, Health, United States, 1999, with Health and Aging Chartbook
10. Demography is not destiny. Washington, DC: National Academy on Aging Society; 1999
11. Incidence and preventability of adverse drug events in nursing homes
12. What does medicare pay for? Disentangling the flow of funds to health care providers
13. Pharmacy practice in the long term care environment
14. Validity and responsiveness of the minimum data set
15. Psychometric characteristics of the minimum data set, II: Validity
16. Psychometric characteristics of the minimum data set, I: Confirmatory factor analysis
17. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update
18. Prescription Drug User Fees (concerning the Prescription Drug User Fee Act (PDUFA))
19. State Operations Manual: Guidance to Surveyors - Long Term Care Facilities
20. Re-engineering the medication use system
21. Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations
22. The use of mechanical and chemical restraints in nursing homes
23. A study of antipsychotic drug use in nursing homes: Epidemiologic evidence suggesting misuse
24. Psychotropic drug use and the risk of hip fracture
25. The impact of clinical pharmacists' consultations on physicians' geriatric drug prescribing. A randomized controlled trial
26. A randomized, controlled trial of a clinical pharmacists intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy
27. Clinical and economic effects of pharmacy services in a geriatric ambulatory clinic
28. Impact of pharmacist-conducted patient assessment on the drug regimen review process
29. The health care cost of drug-related morbidity and mortality in nursing facilities
30. The Fleetwood Model: An enhanced method of pharmacist consultation
31. Fleetwood phase II tests a new model of long-term care pharmacy
32. MDS - MedGuide®
33. Benchmarking in health care: Turning challenges into success
34. Opportunities and responsibilities in pharmaceutical care
35. Drug-regimen review in pharmaceutical care: Regulation versus resident centered review
36. New Jersey Administrative Code. Title 13, Chapter 39, Subchapter 1: General provisions
37. Competency, board certification, credentialing, and specialization: Who benefits?
38. From outcomes research to disease management: A guide for the perplexed
39. Lessons learned from projects in disease management in ambulatory care
40. Large LTC providers set the pace
41. Small area variations in health care delivery: A population-based health information system can guide planning and regulatory decision making
42. The unintended consequences of measuring quality on the quality of medical care
43. Clinton to order federal agencies to reduce medical errors
44. Type I accreditation recommendations
45. Delivering or facilitating clinical care
46. Risk adjustment methods for health outcomes assessments: General approaches